Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 20:24-33, 2002
© American Diabetes Association ®, Inc., 2002


Position Statement

Standards of Medical Care for Patients With Diabetes Mellitus

Originally approved 1988. Most recent review/revision, October 2001 Abridged from Diabetes Care 25:213–229, 2002.[Full Text]

Full text of this position statement is available on the ADA Web site at http://care.diabetesjournals.org/cgi/content/full/25/1/213


    Introduction
 
Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes.

These standards of care are intended to provide clinicians, patients, researchers, payers, and other interested persons with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed. For more detailed information, refer to Skyler (Ed.): Medical Management of Type 1 Diabetes and Zimmerman (Ed.): Medical Management of Type 2 Diabetes.

The recommendations included are diagnostic and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the Association and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations.


View this table:
[in this window]
[in a new window]
 
Table 1. ADA evidence grading system for clinical practice recommendations

 

    CLASSIFICATION, DIAGNOSIS, AND SCREENING
 
Classification
In 1997, the American Diabetes Association issued new diagnostic and classification criteria.

The classification of diabetes mellitus includes four clinical classes

  • Type 1 diabetes (ß-cell destruction, usually leading to absolute insulin deficiency)
  • Type 2 diabetes (Results from a progressive insulin secretory defect on the background of insulin resistance)
  • Other specific types of diabetes (due to other causes, e.g., genetic defects in ß-cell function, genetic defects in insulin action, diseases of the exocrine pancreas, drug or chemical induced)
  • Gestational diabetes mellitus (GDM) (diagnosed during . . . [Full Text of this Article]

Diagnosis
Screening
Detection and diagnosis of GDM
Recommendations
A-Level evidence

Expert consensus

    INITIAL EVALUATION
 
Glycemic control
Referral for diabetes management
Recommendations
A-Level Evidence

B-Level Evidence
Expert consensus
Assessment of glycemic control
Self-monitoring of blood glucose
Recommendations
Expert consensus

A1C
Recommendations
Expert consensus

MNT
Recommendations
B-Level evidence

Physical Activity
Recommendations
B-Level evidence


    PREVENTION AND MANAGEMENT OF DIABETES COMPLICATIONS
 
Cardiovascular disease: management of risk factors and screening for CAD
Blood pressure control
Recommendations
Screening and Diagnosis
Expert consenus

Treatment
A-Level evidence

B-Level evidence
C-Level evidence
Expert consensus
Lipid management
Recommendations
General recommendations
A-Level evidence

B-Level evidence
Goals
B-Level evidence

C-Level evidence
Screening
Expert consensus

Treatment
A-Level evidence

Aspirin therapy in diabetes
Recommendations
A-Level evidence

B-Level evidence
Smoking Cessation
Recommendations
A-Level evidence

B-Level evidence
CHD screening and treatment
Recommendations
Expert consensus


    SCREENING AND MANAGEMENT OF OTHER COMPLICATIONS
 
Nephropathy screening and treatment
General recommendations
A-Level evidence

Screening
Expert consensus

Treatment
A-Level evidence

B-Level evidence
Expert consensus
Foot care
Recommendations
A-Level evidence

B-Level evidence
C-Level evidence
Expert consensus
Diabetic retinopathy screening and treatment
General Recommendations
A-Level evidence

Screening
B-Level evidence

Treatment
A-Level evidence


    PREVENTIVE CARE
 
Preconception Care
Recommendations
B-Level evidence

C-Level evidence
Expert consensus
Immunization
Recommendations
C-Level evidence


    Footnotes
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.